Birdwatch Note
2024-11-26 15:52:19 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
La prise d'hydroxychloroquine associée ou non à l’azithromycine dans le traitement du Covid-19 ne montre pas de bénéfice clinique https://ansm.sante.fr/actualites/lansm-rappelle-que-lhydroxychloroquine-lazithromycine-et-livermectine-ne-constituent-pas-des-traitements-du-covid-19 Des effets indésirables allant jusqu'à la mort ont été constaté https://www.sanofi.com/assets/countries/canada/docs/products/prescription-products/hydroxychloroquine-dhcpl-fr.pdf https://www.ladepeche.fr/2024/01/04/covid-19-lhydroxychloroquine-responsable-de-17-000-deces-dans-six-pays-dont-la-france-selon-une-etude-11676462.php Le bénéfice risque en traitement du covid est donc négatif
Written by 2525A116715768A7CC42C4D4C38E8A47813D758DA9DE7F9DD237BFCE01BDCADB
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1838332549388537876
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1861437841521201242
- noteId - 1861437841521201242
- participantId -
- noteAuthorParticipantId - 2525A116715768A7CC42C4D4C38E8A47813D758DA9DE7F9DD237BFCE01BDCADB Participant Details
- createdAtMillis - 1732636339919
- tweetId - 1838332549388537876
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- La prise d'hydroxychloroquine associée ou non à l’azithromycine dans le traitement du Covid-19 ne montre pas de bénéfice clinique https://ansm.sante.fr/actualites/lansm-rappelle-que-lhydroxychloroquine-lazithromycine-et-livermectine-ne-constituent-pas-des-traitements-du-covid-19 Des effets indésirables allant jusqu'à la mort ont été constaté https://www.sanofi.com/assets/countries/canada/docs/products/prescription-products/hydroxychloroquine-dhcpl-fr.pdf https://www.ladepeche.fr/2024/01/04/covid-19-lhydroxychloroquine-responsable-de-17-000-deces-dans-six-pays-dont-la-france-selon-une-etude-11676462.php Le bénéfice risque en traitement du covid est donc négatif
Note Ratings
| rated at | rated by | |
| 2024-11-26 15:34:26 -0600 | Rating Details |